NIKKEI 225
27,011.33 -120.01 (-0.44%) HANG SENG
24,289.90 +46.29 (+0.19%) CRUDE OIL
87.32 +1.72 (+2.01%) GOLD FUTURES
1,817.70 -34.80 (-1.88%) DOW
34,168.09 -129.64 (-0.38%) BTC-GBP
27,059.06 -274.06 (-1.00%)
MorphoSys AG (MOR.DE)
| Previous close | 25.38 |
| Open | 25.55 |
| Bid | 26.33 x 1500 |
| Ask | 26.37 x 8800 |
| Day's range | 25.55 - 27.10 |
| 52-week range | 25.21 - 101.25 |
| Volume | |
| Avg. volume | 349,974 |
| Market cap | 900.981M |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
MorphoSys AG (MOR) Q3 2021 Earnings Call Transcript
My name is Julia Neugebauer, Senior Director, Investor Relations of MorphoSys and it is my pleasure to welcome you to our third quarter 2021 financial results conference call. Joining me on the call today are Jean-Paul Kress, Chief Executive Officer; Sung Lee, Chief Financial Officer; and Malte Peters, Chief Research and Development Officer.
- Zacks
Wall Street Analysts Think MorphoSys AG Unsponsored ADR (MOR) Could Surge 71%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 71.3% in MorphoSys AG Unsponsored ADR (MOR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
MorphoSys AG Unsponsored ADR (MOR) Upgraded to Strong Buy: Here's What You Should Know
MorphoSys AG Unsponsored ADR (MOR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
